Track topics on Twitter Track topics that are important to you
Zymergen announced a $400+ million Series C funding round in support of its proprietary technology platform to produce novel and improved molecules to meet global-scale industrial needs. The majority ...
Zymergen, molecular manufacturing tech co. Announces $400M in Series C Funding led by the SoftBank Vision Fund https://www.businesswire.com/news/home/20181213005198/en/Zymergen-Announces-400-Million-Series-Funding-led …
Zymergen, molecular manufacturing tech co. Announces $400M in Series C Funding led by the SoftBank Vision Fund https://www.businesswire.com/news/home/20181213005198/en/Zymergen-Announces-400-Million-...
Molecular technology company expands manufacturing leadership with appointment of former Tesla Vice President and LEGO Group executive Zymergen, the world's first molecular ma...
Your guide to what’s new in synthetic biology Hi all, It’s been a phenomenal week for the synthetic biology industry with $1.2B flowing into the industry from a couple of big IPOs and s...
Institutional investors rally behind molecular technology’s blue-chip market opportunity Zymergen, the world’s first molecular manufacturing technology company, ann...
Zymergen is a molecular technology company ushering in a new age of manufacturing and industrial innovation. Leveraging the power of machine learning, automation, and bioengineeri...
We have published hundreds of Zymergen news stories on BioPortfolio along with dozens of Zymergen Clinical Trials and PubMed Articles about Zymergen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zymergen Companies in our database. You can also find out about relevant Zymergen Drugs and Medications on this site too.